Aging (Aging-US) Research

Aging News & Blogs

Dr. Blagosklonny’s Rapamycin-Based Recommendation for Altos Labs

Mikhail Blagosklonny, M.D., Ph.D., has a recommendation for Altos Labs in his new research perspective, entitled, “Altos Labs and the quest for immortality: but can we live longer right now?”

Continue reading

May 12, 2022

TP53 Restoration Sensitizes Pancreatic Cancer to Multiple Drugs

May 4, 2022

In Aging’s Volume 14, Issue 8, cover paper, researchers found that the restoration of wild-type TP53 decreased pancreatic cancer cell resistance to various drugs, including rapamycin. … continue reading
Trending With Impact: Tobacco PEBP Increases Lifespan in Fruit Flies

April 28, 2022

Researchers conducted an interspecies analysis to determine the effects on aging that occur when certain plant proteins are expressed in animals and animal proteins are expressed in plants. … continue reading
Trending With Impact: Underlying Mechanisms of Replicative Senescence

April 21, 2022

Published on the cover of Aging’s Volume 14, Issue 7, researchers conducted a new study investigating the role of IGFBP5 in replicative senescence. … continue reading
Protein Linked to Aging-Related Muscle Loss

April 13, 2022

Researchers investigated the mitochondrial protein GRSF1 for its role in the physiology of skeletal muscle aging. … continue reading

View More Posts

Aging: Volume 14, Issue 9

Single-cell transcriptomics reveals age-resistant maintenance of cell identities, stem cell compartments and differentiation trajectories in long-lived naked mole-rats skin

Naked mole-rats (NMR) are subterranean rodents characterized by an unusual longevity coupled with an unexplained resistance to aging. In the present study, we performed extensive in situ analysis and single-cell RNA-sequencing comparing young and older animals…

May 15, 2022

Read Aging’s Latest Publications

Insights From Authors and Announcements

Visit Aging-US.net

ABOUT AGING-US.ORG

Aging-US.org features weekly articles describing new and trending research papers published by Aging (Aging-US)—a twice-monthly, traditional, peer-reviewed journal with open access, covering all areas of research on aging, including age-related diseases, such as cancer.

The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases and prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.

Impact Journals, the publisher of Aging (Aging-US), meets the standards of the Wellcome Trust Publisher Requirements and was included in the Wellcome Trust List of Compliant Publishers.